Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sabine Seidel"'
Autor:
Sabine Seidel, Verena Nilius-Eliliwi, Thomas Kowalski, Deepak Ben Vangala, Uwe Schlegel, Roland Schroers
Publikováno v:
Cancers, Vol 14, Iss 9, p 2100 (2022)
High-dose chemotherapy with autologous stem cell transplantation (HCT-ASCT) is reportedly an effective treatment strategy in relapsed or refractory primary CNS lymphoma (r/r PCNSL); however, only selected patients are eligible for this treatment. We
Externí odkaz:
https://doaj.org/article/b054ebd82438458dbaae166238db0ae9
Autor:
Sabine Seidel, Michelle Margold, Thomas Kowalski, Alexander Baraniskin, Roland Schroers, Agnieszka Korfel, Eckhard Thiel, Michael Weller, Peter Martus, Uwe Schlegel
Publikováno v:
Cancers, Vol 13, Iss 12, p 2934 (2021)
Patients with primary central nervous system lymphoma (PCNSL) not fulfilling inclusion criteria for clinical trials represent an underreported population. Thirty-four consecutive PCNSL patients seen at our center between 2005 and 2019 with exclusion
Externí odkaz:
https://doaj.org/article/3ed803e0b1b845808d80f3e09e047c88
Autor:
Daniel M. Waldera-Lupa, Gereon Poschmann, Nina Kirchgaessler, Omid Etemad-Parishanzadeh, Falk Baberg, Mareike Brocksieper, Sabine Seidel, Thomas Kowalski, Anna Brunn, Aiden Haghikia, Ralf Gold, Anja Stefanski, Martina Deckert, Uwe Schlegel, Kai Stühler
Publikováno v:
Cancers, Vol 12, Iss 7, p 1732 (2020)
Primary central nervous system lymphomas (PCNSL) account for approximately 2% to 3% of all primary brain tumors. Until now, neuropathological tumor tissue analysis, most frequently gained by stereotactic biopsy, is still the diagnostic gold standard.
Externí odkaz:
https://doaj.org/article/ced6b53f3a8541f39b502bf26c4b154a
Autor:
Agnieszka Korfel, Michelle Margold, Sabine Seidel, Peter Martus, Thomas Kowalski, Alexander Baraniskin, Uwe Schlegel, Roland Schroers, Eckhard Thiel, Michael Weller
Publikováno v:
Cancers, Vol 13, Iss 2934, p 2934 (2021)
Cancers
Volume 13
Issue 12
Cancers
Volume 13
Issue 12
Patients with primary central nervous system lymphoma (PCNSL) not fulfilling inclusion criteria for clinical trials represent an underreported population. Thirty-four consecutive PCNSL patients seen at our center between 2005 and 2019 with exclusion